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Introduction
Figure 1. Hydrolysis of Acetylcholine (ACh) to Choline by AChE
OP nerve agents are
substrate analogues of
ACh that irreversibly inhibit
AChE by reacting in the
enzyme’s active site.Figure 2. Library of Organophosphorus 
(OP) Nerve Agents
• Inhibited AChE can be reactivated by oximes to yield native
AChE
• Aging occurs when the OP-AChE adduct is dealkylated
• Oxime treatment is ineffective on the aged form of AChE
• Quinone methides (QM) can potentially realkylate aged AChE
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Figure 3. Inhibition and Aging of AChE
• Synthesize a library of quinone methide precursors
(QMPs) that will generate active electrophilic quinone
methides (QMs) in situ
• Investigate their ability to realkylate model
phosphonates and the aged form of AChE
• If alkylated, reactivation of inhibited AChE is possible
(treatment with oximes)
QMs as Alkylating Agents
Figure 4. Alkylation of Aged AChE by QM in situ
Design and Synthesis of QMP Library
Figure 5. Synthesis of QMPs by Mannich Reaction
Figure 6. Synthesis of QMPs by Reductive Amination
Figure 7. Selection of Amine 
Leaving Groups
Final QMPs will have
protonated and methylated
amine leaving groups
Synthesis of Model Phosphonate
Figure 8. Synthesis of Model Phosphonate from Methyl 
Phosphonic Dichloride
Studies show model phosphonate
of interest to be non-toxic as it
failed to inhibit AChE
Nucleophilicity of Model Phosphonate
Figure 9. Model Phosphonate Reaction with Benzyl Bromide
Future Directions
Screen QMP library for reaction with model phosphonate
and monitor it by 31P-NMR spectroscopy
https://research.cbc.osu.edu/hadad.1/
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Figure 10. 31P-NMR Data
Acknowledgements
Financial support from NIH grant 1U01–NS087983 
